title: Maternal characteristics, neonatal outcome, and the time of diagnosis of gestational diabetes.
abstract: OBJECTIVE
  A study was undertaken to evaluate the yield of early, routine screening for gestational diabetes and to determine whether maternal characteristics and neonatal outcome differ according to the time of diagnosis.
  
  
  METHODS
  A total of 2776 women were screened before 24 weeks of gestation, and each was delivered of a singleton infant on the clinic service of Mount Sinai Hospital in New York City between January 1986 and January 1991.
  
  
  RESULTS
  An abnormal glucose tolerance test was diagnosed in 102 women < 24 weeks and in 252 patients at > or = 24 weeks of gestation. Logistic regression analysis showed that the group diagnosed early was significantly older and more likely to have hypertensive disorders and low maternal weight gain and to require insulin treatment, compared with the group diagnosed late. No significant differences were evident in neonatal outcome.
  
  
  CONCLUSIONS
  These data indicate that a sizable proportion of patients with gestational diabetes can be diagnosed early in pregnancy. The differences in maternal characteristics and insulin requirements between the early- and late-diagnosis groups also suggest heterogeneity of gestational diabetes or the possibility of preexisting impaired glucose intolerance in the early-diagnosis group.
authors.affiliation: Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai School of Medicine, New York, New York.
authors.forename: G S
authors.initials: GS
authors.lastname: Berkowitz
authors.forename: S H
authors.initials: SH
authors.lastname: Roman
authors.forename: R H
authors.initials: RH
authors.lastname: Lapinski
authors.forename: M
authors.initials: M
authors.lastname: Alvarez
mesh_terms: D016640:Diabetes, Gestational / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology; D005260:Female; D005865:Gestational Age; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D011247:Pregnancy / Q000502:physiology*; D011256:Pregnancy Outcome; D012044:Regression Analysis; D012307:Risk Factors; D013997:Time Factors
chemical_list: D007328:Insulin